Specifically, Zong Z. and colleagues recently demonstrated that IGFBP-6 is an unfavorable prognostic factor in glioma, affecting tumor malignancy with an expression positively correlated with the immunosuppressive response in glioma patients [75]. Here, IGFBP6 is linked to neoplasm.